Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 6/20 | 0.69 |
| ▸ | ACHE | P22303 | 8/20 | 0.57 |
| ▸ | CASP2 | P42575 | 1/20 | 0.52 |
| ▸ | MGLL | Q99685 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3899913 | 0.98 | EPHX1 (0.73) | EPHX1ACHECASP2 | |
| SCHEMBL28524618 | 0.98 | EPHX1 (0.73) | EPHX1ACHECASP2 | |
| SCHEMBL28747970 | 0.98 | EPHX1 (0.73) | EPHX1ACHECASP2 | |
| SCHEMBL3462778 | 0.93 | — | — | |
| SCHEMBL443246 | 0.84 | EPHX1 (0.95) | EPHX1ACHECASP2 | |
| SCHEMBL851201 | 0.83 | — | — | |
| SCHEMBL3910901 | 0.82 | EPHX1 (1.00) | EPHX1ACHECASP2MGLL | |
| SCHEMBL1616893 | 0.82 | EPHX1 (1.00) | EPHX1ACHECASP2MGLL | |
| SCHEMBL717504 | 0.82 | EPHX1 (1.00) | EPHX1ACHECASP2MGLL | |
| SCHEMBL13387440 | 0.82 | EPHX1 (1.00) | EPHX1ACHECASP2MGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105709229-A | Novel lipids and compositions for the delivery of therapeutics | 阿尔尼拉姆医药品有限公司 | 2016-06-29 | — | — | CN | disclosed |
| CN-102361650-B | Lipids and compositions for delivery of therapeutic agents | ALNYLAM PHARMACEUTICALS, INC. (US) | 2016-04-20 | — | — | CN | disclosed |
| CN-105152939-A | Lipids and compositions for the delivery of therapeutics | ALNYLAM PHARMACEUTICALS INC | 2015-12-16 | — | — | CN | disclosed |
| CN-104873464-A | Improved lipid formulation | ALNYLAM PHARMACEUTICALS INC | 2015-09-02 | — | — | CN | disclosed |
| CN-102281899-B | Lipids and compositions for delivery of therapeutic agents | ALNYLAM PHARMACEUTICALS INC | 2015-07-15 | — | — | CN | disclosed |
| CN-102625696-B | Improved lipid formulations | ALNYLAM PHARMACEUTICALS INC | 2015-06-03 | — | — | CN | disclosed |
| CN-102105496-A | Method of making carbamate functional materials | BASF CORP | 2011-06-22 | — | — | CN | disclosed |
| EP-2197921-A1 | METHOD OF MAKING CARBAMATE FUNCTIONAL MATERIALS | BASF Coatings GmbH (US) | 2010-06-23 | — | — | EP | disclosed |
| WO-2009035667-A1 | METHOD OF MAKING CARBAMATE FUNCTIONAL MATERIALS | BASF CORPORATION (US) | 2009-03-19 | — | — | WO | disclosed |
| EP-1362074-B1 | CARBAMATE FUNCTIONAL POLYMERS AND OLIGOMERS | BASF CORP (US) | 2009-02-18 | — | — | EP | disclosed |
| US-6710138-B2 | NONDEFORMING, SPRAYABLE, CHEMICAL RESISTANCE; CURABLE POLYURETHANES | BASF CORPORATION | 2004-03-23 | — | — | US | disclosed |
| EP-1362074-A1 | CARBAMATE FUNCTIONAL POLYMERS AND OLIGOMERS | BASF CORPORATION (US) | 2003-11-19 | — | — | EP | disclosed |
| US-20030144429-A1 | Carbamate functional polymers and oligomers | OHRBOM WALTER H (US) | 2003-07-31 | — | — | US | disclosed |
| US-6541577-B2 | High solids coatings | BASF CORPORATION | 2003-04-01 | — | — | US | disclosed |
| US-20020147279-A1 | Carbamate functional polymers and oligomers | BASF CORPORATION | 2002-10-10 | — | — | US | disclosed |
| WO-2002046261-A1 | CARBAMATE FUNCTIONAL POLYMERS AND OLIGOMERS | BASF CORPORATION, PLEASE SEE GENERAL APPOINTMENT OF REPRESENTATIVE (US) | 2002-06-13 | — | — | WO | disclosed |